Zimmer Biomet Holdings, Inc. (ZBH) Financials
ZBH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 21.5 billion | 9.0 billion |
2023-09-30 | 21.2 billion | 8.7 billion |
2023-06-30 | 21.3 billion | 8.9 billion |
2023-03-31 | 21.2 billion | 9.1 billion |
ZBH Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 446.7 million | 25.3 million |
2023-09-30 | 240.2 million | 15.6 million |
2023-06-30 | 177.3 million | 33.9 million |
2023-03-31 | 261.0 million | 25.0 million |
ZBH Net Income
Date | Net Income |
---|---|
2023-12-31 | 419.1 million |
2023-09-30 | 162.8 million |
2023-06-30 | 209.8 million |
2023-03-31 | 232.8 million |
ZBH Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 415.8 million | - | - |
2023-09-30 | 292.1 million | 5.1 billion | - |
2023-06-30 | 319.8 million | 5.2 billion | - |
2023-03-31 | 330.2 million | 5.2 billion | - |
ZBH Shares Outstanding
ZBH Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 141.7 million | 113.3 million | 722.3 million | - |
2023-09-30 | 97.4 million | 116.9 million | 674.9 million | - |
2023-06-30 | 170.6 million | 118.1 million | 725.8 million | - |
2023-03-31 | 46.7 million | 110.4 million | 715.9 million | - |
ZBH Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.9 billion | 538.8 million |
2023-09-30 | 1.8 billion | 518.6 million |
2023-06-30 | 1.9 billion | 525.5 million |
2023-03-31 | 1.8 billion | 500.8 million |
ZBH
Price: $119.43
Dividend Yield: 0.01%
Forward Dividend Yield: 0.80%
Payout Ratio: 44.86%
Dividend Per Share: 0.96 USD
Earnings Per Share: 4.88 USD
P/E Ratio: 59.60
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 22261
Ebitda: 235.3 millionMarket Capitalization: 26.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR3: 1.02%
DGR5: 0.62%
DGR10: 3.64%